Agarwal Industrial Corporation Limited shines again, reports 277% Growth in PAT in Q1FY22 (YOY)

Mumbai, August 17: Agarwal Industrial Corporation Limited (BSE: 531921 |NSE: AGARIND ), one of India’s largest integrated players in Bitumen, continued its growth trajectory closing the first quarter of F.Y. 2021-22 with triple-digit growth in both top and bottom line.

The Consolidated Revenue of the Company grew 177% (YoY) to Rs. 407.94 Crore. The company, along with its subsidiaries, continued to maintain its track record of consistent growth performance. The consolidated profit after tax grew 277% YoY to Rs. 15.07Crore. The company has built a credible track record in building scale and delivering high growth consistently. PAT margin of the company stood at 3.68% as compared to 2.7% in the last quarter.  The Board of the Company has declared a final dividend of INR 1.80, subject to the approval of shareholders.

Highlights of the Quarter Ended June 30, 2021

(Consolidated)

(Standalone)

Amt.

(Rs. in Crore)

% Growth (YoY)

Amt.

(Rs. in Crore)

% Growth (YoY)

Total Revenue

409.23

176.69%

366.94

170.96%

EBITDA

25.51

181.57%

16.20

181.40%

EBITDA Margin

6.23%

4.42%

PAT

15.07

276.99%

7.18

498.36%

PAT Margin

3.68%

1.96%

EPS (Not Annualized) (in Rs.)

12.84

229.23%

6.12

423.08%

Commenting on the successful results:

Mr. Lalit Agarwal, Whole Time Director, Agarwal Industrial Corporation Limited, said, “AICL is consistently pursuing its goal of accelerated high-value growth. In the first quarter, once again, we delivered – with strong and profitable growth in all businesses. The strong performance of our company was demonstrated in the first quarter by triple-digit revenue growth and increased profitability. With a strong liquidity position, a demonstrated ability to deliver execution and profitability, we are confident of weathering the crisis as well as to capture opportunities in a resilient non-recession market of Bitumen.”

Mr. Jaiprakash Agarwal, Managing Director, Agarwal Industrial Corporation Limited, said:  “Q1FY22 marks yet another robust quarter with strong progress driven by petrochemical business. This quarter led to the successful acquisition of Agarwal Translink Private Limited, which is believed to be a definitive step toward strengthening financials and unlocking of higher value and greater opportunities in the logistics segment. Our endeavor to strengthen our balance sheet and improve business visibility and stability continues – which will be forming the basis for growth going forward.”

Related Posts

Flite Launches its Festive Collection with a Bang: Make a DhamakedaarEntry this Festive Season

New Delhi [India] September 18: Festive season is around the corner, that time of the year when everyone loves to dress up and no outfit is truly complete without the…

Swami Vivekanand International School goes green with support of BMC and Environmentalists

New Delhi [India], September 18: Swami Vivekanand International School and Junior College has taken a significant step towards promoting environmental awareness by hosting the “Empowering Tomorrow: Environmental and Sustainability Education…

You Missed

The Revolutionary AI Health Monitoring Tool Every Indian Should Know About

The Revolutionary AI Health Monitoring Tool Every Indian Should Know About

Healing Hospital Chandigarh Achieves Groundbreaking Success in Sleep Apnea Surgery for High BMI Patient

Healing Hospital Chandigarh Achieves Groundbreaking Success in Sleep Apnea Surgery for High BMI Patient

The Hidden Dangers of Modern Lifestyle Habits: A Growing Cancer Concern

The Hidden Dangers of Modern Lifestyle Habits: A Growing Cancer Concern

Sunpure Research Incubation Centre secures patent for “CURCUBOOST”

Sunpure Research Incubation Centre secures patent for “CURCUBOOST”

India’s First Mental Health Education Program: Empowering Teachers and Upskilling for the 21st Century

India’s First Mental Health Education Program: Empowering Teachers and Upskilling for the 21st Century

IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India

IPCA Laboratories Ltd launches Diulcus to address Diabetic Foot Ulcer (DFU) in India